Competing risk model for the ATE effect. by Giulia Barbati (4093843)

“…Competing risk models on weighted cohorts were used to derive the Average Treatment Effect (ATE) and the Conditional Average Treatment Effect (CATE) in subgroups of interest. …”

Propensity score diagnostics for the ATE effect estimation. by Giulia Barbati (4093843)

Average Treatment Effect (ATE) for the different scenarios analyzed. by Juan David Gutiérrez (6511763)

Cause-specific cumulative hazard curves estimated for the ATE effect. by Giulia Barbati (4093843)

The ATE evaluation values of different SLAM. by Wang Yang (311439)

“…Second, the lightweight YOLOv8n model is integrated to detect and remove feature points in dynamic regions in real-time, effectively reducing the impact of dynamic interference on pose estimation. …”

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

Significantly Enriched Pathways. by Jiyong Zhang (2498740)

Subjects:

Decrease of injuries. by Petr Fulin (8380320)

Subjects:

The level of miRNA 221 in the myocardium of MIRI mice was decreased. by Hongyu Li (1332669)

Subjects:

Decrease of admissions and lead diagnoses. by Petr Fulin (8380320)

Subjects:

Map of Pakistan with marked Punjab province. by Sumaira Sumaira (21453523)

The Mann-Whitney U test (M.W.) analysis reflects the significant differences between mutated groups and non-mutated groups of mutated genes with high ATE values in the activity of... by Yijun Liu (205209)

The Mann-Whitney U test (M.W.) analysis reflects the significant differences between mutated groups and non-mutated groups of mutated genes with high ATE values in the activity of... by Yijun Liu (205209)

Significant relationships between QOL measures on infusion day and day 7. by Jordan K. Abbott (8934239)

Subjects:

Sensitivity analyses of seroprevalence with the largest sample size study omitted. by Yu Zhou (89766)

Chronic colitis induces marked changes in protein expression in the adult heart and blood. by Yanbo Tang (11457519)

Deletion of <i>sagA</i> alone results in a decrease in nasopharyngeal infection. by Blake A. Shannon (14197601)

Generalizable improvement of QOL measures on day 7 vs. infusion day. by Jordan K. Abbott (8934239)

Subjects:

Cabozantinib significantly decreases tumor volume and prolongs survival in SCNPC PDX models. by Mark P. Labrecque (10011469)

Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts. by Gillian P. McHugo (8965919)